Effect of Mulberry Fruit Powder in Metabolic Syndrome - Trial NCT05956106
Access comprehensive clinical trial information for NCT05956106 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Veterinary and Animal Sciences, Lahore - Pakistan and is currently Not yet recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Veterinary and Animal Sciences, Lahore - Pakistan
Timeline & Enrollment
N/A
Aug 01, 2023
Dec 01, 2023
Primary Outcome
Lipid profile will be assessed before and after the trial.,Fasting glucose level will be assessed before and after the trial,Weight circumference will be measured before and after the trial,Blood pressure will be assessed before and after the trial.
Summary
Metabolic syndrome is a raising concern globally, especially in developing countries such as
 Pakistan. To prevent its risk factors diet and lifestyle modification is major solution.
 Functional foods have additional benefits of treating disease while providing basic
 nutrients. Mulberry is a native fruit with the properties of functional food, it is rich in
 anthocyanin and different anti-obesity,anti-diabetic, and anti-hyperlipidemic treating
 potential antioxidants. Mulberry will prove its therapeutic potential against the risk
 factors of metabolic syndrome.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05956106
Non-Device Trial